Showing 2,841 - 2,860 results of 3,006 for search '(( significantly reported decrease ) OR ( significantly ((better decrease) OR (teer decrease)) ))', query time: 0.53s Refine Results
  1. 2841

    Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  2. 2842

    Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  3. 2843

    Data Sheet 5_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  4. 2844

    Data Sheet 2_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  5. 2845

    Data Sheet 10_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  6. 2846

    Data Sheet 12_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  7. 2847

    Data Sheet 6_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

    Published 2025
    “…The SGLT2i group also demonstrated significant improvement in MELD-Na, MELD 3.0 and CTP scores, with greater resolution of hepatic decompensations, proteinuria, as well as better BMI and HbA1c outcomes (all p < 0.01).…”
  8. 2848

    Data for: Soil microplastics pollution can reduce viral abundance and have less consistent impacts on bacteria by Wen-Wen Huang (22122439)

    Published 2025
    “…In both experiments, PE and PVC significantly reduced viral abundances. However, their effects on bacterial abundances were context-dependent. …”
  9. 2849

    <b>Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis</b> by jiewen zhong (21472721)

    Published 2025
    “…In a mouse model of liver fibrosis, the cRLN2 treatment significantly decreased hepatic stellate cell activation and consequently reduced collagen deposition in fibrotic mice, while the treatment by relaxin protein showed limited anti-fibrosis effects. …”
  10. 2850

    <b>Targeted Inhibition of Tumor-Intrinsic SIRPα Improve anti-PD-1 Resistance by Enhancing T Cell Immunity and Inhibits</b><b> Tumor </b><b>Proliferation in Esophageal Cancer: Thera... by Xi-Yang Tang (13184496)

    Published 2025
    “…Apoptosis of PBMC and Jurkat T cell were significantly decreased cocultured with SIRPA knockdown esophageal cells. …”
  11. 2851

    Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial by Pringgodigdo Nugroho (15460802)

    Published 2025
    “…Although UACR decreased more in the calcitriol group, the difference was not statistically significant (<i>p</i> = 0.099). …”
  12. 2852

    The Effect of Chronic Stress on Apoptosis Regulation and Oncogenesis Evolution: A Theoretical Approach. by DIMITRIOS KIMOGLOU (20499350)

    Published 2025
    “…The following presentation describes these pathways in depth, provides clinical data, and conducts biochemical investigations, all of which contribute to a better understanding of the link between mental health and cellular malfunction.…”
  13. 2853

    Astaxanthin mediated repair of tBHP-Induced cellular injury in chondrocytes by Wenwei Liang (9286389)

    Published 2024
    “…In the osteoarthritis mouse model, they effectively decreased joint inflammation and increased the expression of chondrocyte markers.…”
  14. 2854

    Emissions, spectrum and simulation data for gliding arc plasma assisted NH3-air mixtures for different global equivalence ratios by Aravind Balakrishnan (19086065)

    Published 2025
    “…It is the first to focus on generating NH₂ radicals through plasma actuation while maintaining OH production, thereby promoting the De-NOₓ pathway and significantly decreasing NOₓ emissions. Additionally, the present combustor achieves 45–60% reduction in NOₓ emissions while consuming only 1.4% of the power compared to existing literature.…”
  15. 2855

    Preliminary efficacy of eye movement desensitization and reprocessing for children aged 1.5–8 years with PTSD: a multiple baseline experimental design (<i>N</i> = 19) by Carlijn de Roos (8061239)

    Published 2025
    “…There was no dropout (0%) and no adverse events were reported.</p> <p><b>Conclusions:</b> The findings provide preliminary evidence of the safety, feasibility, and efficacy of six sessions of EMDR therapy for reducing paediatric PTSD and comorbidity in young children aged 1.5–8 years and, at the same time, decreasing parenting stress. …”
  16. 2856

    Image 1_Effective control of the emerging PEDV G2-c variant with an inactivated autogenous vaccine.png by Huan Xu (38476)

    Published 2025
    “…Remarkably, piglet mortality rates decreased significantly within 2 weeks post-vaccination. …”
  17. 2857

    Image 3_Effective control of the emerging PEDV G2-c variant with an inactivated autogenous vaccine.png by Huan Xu (38476)

    Published 2025
    “…Remarkably, piglet mortality rates decreased significantly within 2 weeks post-vaccination. …”
  18. 2858

    Image 2_Effective control of the emerging PEDV G2-c variant with an inactivated autogenous vaccine.png by Huan Xu (38476)

    Published 2025
    “…Remarkably, piglet mortality rates decreased significantly within 2 weeks post-vaccination. …”
  19. 2859

    Data Sheet 3_Epidemiology of inflammatory bowel disease-associated anemia in children and adolescents from 1990 to 2021: a global, regional analysis from the Global Burden of Disea... by Chenjing Xu (12109035)

    Published 2025
    “…</p>Conclusion<p>The ASPR of IBD-associated anemia in children and adolescents increased from 2005 to 2010 and then decreased after reaching a peak in 2010. In the future, IBD-associated anemia will continue to pose a significant public health problem.…”
  20. 2860

    Table1_Maslinic acid induces autophagy and ferroptosis via transcriptomic and metabolomic reprogramming in prostate cancer cells.xlsx by Fen Hu (342627)

    Published 2024
    “…Herein we found that MA inhibits prostate cancer cell proliferation by decreasing CDK2, CDK4, and CDK6 expression and concurrently increasing p27, Rb, p-Rb expression. …”